Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
5,800
Employees5,800
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
5,800
Employees5,800

MRNA Key Statistics

Market cap
12.79B
Market cap12.79B
Price-Earnings ratio
-4.06
Price-Earnings ratio-4.06
Dividend yield
Dividend yield
Average volume
11.39M
Average volume11.39M
High today
$32.80
High today$32.80
Low today
$32.11
Low today$32.11
Open price
$32.20
Open price$32.20
Volume
2.78M
Volume2.78M
52 Week high
$48.92
52 Week high$48.92
52 Week low
$22.28
52 Week low$22.28

Stock Snapshot

The current Moderna(MRNA) stock price is $32.66, with a market capitalization of 12.79B. The stock trades at a price-to-earnings (P/E) ratio of -4.06.

During the trading session on 2025-12-25, Moderna(MRNA) shares reached a daily high of $32.80 and a low of $32.11. At a current price of $32.66, the stock is +1.7% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 2.78M, compared to an average daily volume of 11.39M.

The stock's 52-week range extends from a low of $22.28 to a high of $48.92.

The stock's 52-week range extends from a low of $22.28 to a high of $48.92.

MRNA News

Simply Wall St 6d
There's No Escaping Moderna, Inc.'s Muted Revenues Despite A 28% Share Price Rise

Moderna, Inc. ( ) shareholders have had their patience rewarded with a 28% share price jump in the last month. Not all shareholders will be feeling jubilant, si...

There's No Escaping Moderna, Inc.'s Muted Revenues Despite A 28% Share Price Rise
The Motley Fool 6d
Down 80%, Should You Buy the Dip on Moderna?

Your decision on whether to invest now depends to some extent on your investment strategy. Moderna (MRNA +1.18%) was once the stock everyone rushed to add to t...

Down 80%, Should You Buy the Dip on Moderna?
Seeking Alpha 7d
Moderna granted up to $54.3M from CEPI for bird flu vaccine

The Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership supporting vaccine studies, has agreed to invest up to $54.3M to support a Phas...

Moderna granted up to $54.3M from CEPI for bird flu vaccine

Analyst ratings

62%

of 26 ratings
Buy
19.2%
Hold
61.5%
Sell
19.2%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.